Transmission Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 in High-Density Settings, Minnesota, USA, March-June 2020.

2019 novel coronavirus disease COVID-19 Minnesota SARS-CoV-2 United States coronavirus disease epidemiology respiratory infections severe acute respiratory syndrome coronavirus 2 transmission viruses whole-genome sequencing zoonoses

Journal

Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155

Informations de publication

Date de publication:
08 2021
Historique:
pubmed: 18 6 2021
medline: 24 7 2021
entrez: 17 6 2021
Statut: ppublish

Résumé

Coronavirus disease has disproportionately affected persons in congregate settings and high-density workplaces. To determine more about the transmission patterns of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in these settings, we performed whole-genome sequencing and phylogenetic analysis on 319 (14.4%) samples from 2,222 SARS-CoV-2-positive persons associated with 8 outbreaks in Minnesota, USA, during March-June 2020. Sequencing indicated that virus spread in 3 long-term care facilities and 2 correctional facilities was associated with a single genetic sequence and that in a fourth long-term care facility, outbreak cases were associated with 2 distinct sequences. In contrast, cases associated with outbreaks in 2 meat-processing plants were associated with multiple SARS-CoV-2 sequences. These results suggest that a single introduction of SARS-CoV-2 into a facility can result in a widespread outbreak. Early identification and cohorting (segregating) of virus-positive persons in these settings, along with continued vigilance with infection prevention and control measures, is imperative.

Identifiants

pubmed: 34138695
doi: 10.3201/eid2708.204838
pmc: PMC8314815
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2052-2063

Références

J Infect. 2020 Oct;81(4):621-624
pubmed: 32735893
Nat Commun. 2020 Sep 1;11(1):4376
pubmed: 32873808
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1288-1295
pubmed: 32966272
Science. 2020 Jul 17;369(6501):297-301
pubmed: 32471856
Clin Infect Dis. 2021 Nov 2;73(9):e2823-e2825
pubmed: 32964927
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Clin Infect Dis. 2021 Jul 15;73(2):354-356
pubmed: 32887979
JAMA. 2020 Jul 7;324(1):23-24
pubmed: 32442303
MMWR Morb Mortal Wkly Rep. 2020 Apr 03;69(13):377-381
pubmed: 32240128
Clin Infect Dis. 2021 Jun 1;72(11):e727-e735
pubmed: 32954414
Clin Infect Dis. 2021 Nov 2;73(9):e2827-e2828
pubmed: 32949240
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
Am J Prev Med. 2020 Jun;58(6):888-891
pubmed: 32387174
Clin Infect Dis. 2021 Nov 2;73(9):e2946-e2951
pubmed: 32840608
Nat Med. 2020 Sep;26(9):1398-1404
pubmed: 32647358
Emerg Infect Dis. 2021 Jan;27(1):
pubmed: 33075274
Nat Med. 2020 Sep;26(9):1405-1410
pubmed: 32678356
BMC Genomics. 2017 Dec 6;18(Suppl 10):916
pubmed: 29244005
PLoS One. 2021 Dec 15;16(12):e0260487
pubmed: 34910739
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):587-590
pubmed: 32407300
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
Epidemiol Infect. 2020 Jun 16;148:e254
pubmed: 32539900
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
MMWR Morb Mortal Wkly Rep. 2020 May 29;69(21):651-655
pubmed: 32463809
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
J Infect Dis. 2020 Jun 29;222(2):288-297
pubmed: 32083677
Nature. 2016 Feb 11;530(7589):228-232
pubmed: 26840485
MMWR Morb Mortal Wkly Rep. 2020 Aug 07;69(31):1015-1019
pubmed: 32759914
MMWR Morb Mortal Wkly Rep. 2020 Jul 10;69(27):887-892
pubmed: 32644986

Auteurs

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH